Health Condition 1: null- Chronic liver disease
Conditions
Interventions
Intervention1: Vitamin D and calcium: Cholecalciferol sachet orally (60,000 IU D3/week for first 8 weeks followed by 60,000 IU/month for 10 months along with two oral tablets of calcium carbonate (eac
Sponsors
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: All the consecutive patients with CLD (irrespective of the etiology and the disease severity) having vitamin D deficiency along with hepatic osteodystrophy would be enrolled
Exclusion criteria
Exclusion criteria: 1.Patients undergoing recent contrast study or nuclear medicine test. 2.Pregnant or lactating women 3.Patients with related thyroid, parathyroid disease, cushingâ??s syndrome, diabetes, malignancies, cardiovascular, pulmonary, and renal disease. 4.Patients with a history of immobilization in the past, known cases of osteoporosis on anti-osteoporotic drugs 5.Women with surgical menopause 6.Patients receiving calcium and vitamin D supplementation for 7.Patients receiving medications like steroids, HRT, calcitonin, bisphosphonates, anti-coagulants, anticonvulsants, thyroxine, antiepileptics, interferon, immunosuppressive agents, cholestryamine. 8.Patients with hemachromatosis and Wilsonâ??s disease 9.Patients who refuse to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in level of vitamin D and Bone Mineral Density Timepoint: Baseline and 1 Year | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactProf Anoop Saraya
AIIMS,INDIA
Outcome results
None listed